Apellis Pharmaceuticals Inc. (APLS) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Apellis Pharmaceuticals I...

    NASDAQ: APLS · Real-Time Price · USD
    28.13
    -0.52 (-1.82%)
    At close: Sep 05, 2025, 3:59 PM
    28.50
    1.32%
    After-hours: Sep 05, 2025, 05:29 PM EDT

    Apellis Pharmaceuticals Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 781.37M 396.59M 75.42M 66.56M
    Cost of Revenue
    		 117.72M 58.51M 5.64M 5.2M
    Gross Profit
    		 663.64M 338.08M 69.79M 61.36M
    Operating Income
    		 -164.98M -517.12M -594.61M -536.28M
    Interest Income
    		 12.77M 20.93M 8.91M 418K
    Pretax Income
    		 -196.72M -526.5M -651.5M -746M
    Net Income
    		 -197.88M -528.63M -652.17M -746.35M
    Selling & General & Admin
    		 501.05M 500.81M 277.16M 176.77M
    Research & Development
    		 327.57M 354.39M 387.24M 420.87M
    Other Expenses
    		 n/a n/a -288K 1.36M
    Operating Expenses
    		 828.62M 855.2M 664.4M 597.64M
    Interest Expense
    		 40.39M 29.58M 32.63M 13.24M
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 946.35M 913.71M 670.03M 602.84M
    Income Tax Expense
    		 1.16M 2.13M 669K 352K
    Shares Outstanding (Basic)
    		 123.91M 118.68M 106.11M 84.42M
    Shares Outstanding (Diluted)
    		 123.91M 118.68M 106.11M 84.42M
    EPS (Basic)
    		 -1.6 -4.45 -6.15 -8.84
    EPS (Diluted)
    		 -1.6 -4.45 -6.15 -8.84
    EBITDA
    		 -154.53M -495.21M -617.39M -731.27M
    EBIT
    		 -156.32M -496.92M -618.88M -732.76M
    Depreciation & Amortization
    		 1.8M 1.7M 1.49M 1.49M

    Add to Watchlist